The Hormone Replacement Therapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of hormone replacement therapy has seen robust growth recently. It is projected to increase from $25.06 billion in 2024 to $27.28 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%.
The hormone replacement therapy market is projected to reach $37.9 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.6%.
Download Your Free Sample of the 2025 Hormone Replacement Therapy Market Report and Uncover Key Trends Now!The hormone replacement therapy market covered in this report is segmented –
1) By Therapy Type: Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Replacement Therapy, Other Therapy Types
2) By Indication: Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Other Indications
3) By Route Of Administration: Oral, Transdermal, Injectable, Other Of Administartions
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
The key drivers in the hormone replacement therapy marketare:
• Rising prevalence of hormonal disorders
• Increasing awareness about menopausal health
• Growing global aging population
• Rising demand for minimally invasive treatment options.
The key trends in the hormone replacement therapy market are:
• Advances in bio-identical hormone formulations are emerging as a significant trend.
• The development of advanced transdermal drug delivery systems is shaping the future of the market.
• Personalized hormone therapy based on genetic profiling is a growing trend.
• The implementation of telehealth integration for hormone therapy management is becoming increasingly prevalent.
Major companies in the hormone replacement therapy market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Bayer AG
• Sanofi S.A.
• Abbott Laboratories
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Bausch Health Companies Inc.
• Cipla Inc.
• Gedeon Richter Plc.
• Lupin Limited
• Orion Corporation
• Halozyme Therapeutics Inc.
• Theramex HQ UK Limited
North America was the largest region in the hormone replacement therapy market in 2024